The Goldman Sachs Group, Inc. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-05 5:34 pm Sale |
2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
GOLDMAN SACHS GROUP INC GS |
25,568 0.100% |
-911,439 (-97.27%) |
Filing |
| 2023-02-14 2:40 pm Purchase |
2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
GOLDMAN SACHS GROUP INC GS |
937,006 5.400% |
937,006 (New Position) |
Filing |